(Q43300281)

18 November 2017

Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial (English)

1 reference

18 November 2017

1 reference

1 reference

L E Lundorff

1

1 reference

PubMed ID

19648224

18 November 2017

B H Jønsson

series ordinal

2

1 reference

PubMed ID

19648224

18 November 2017

P Sjøgren

series ordinal

3

1 reference

18 November 2017

31 July 2009

1 reference

18 November 2017

1 reference

18 November 2017

23

1 reference

18 November 2017

8

1 reference

18 November 2017

731-738

1 reference

Symptom evaluation in palliative medicine: patient report vs systematic assessment

18 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Modafinil: a gift to portmanteau

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Modafinil treatment of opioid-induced sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

A prospective trial of modafinil as an adjunctive treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Reliability of the Finger Tapping Test and a Note on Sex Differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

The influence of age on trail making test performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Pharmacokinetic-pharmacodynamic relationships of cognitive and psychomotor effects of intravenous buprenorphine infusion in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Validation of the Edmonton Symptom Assessment Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

The prevalence of psychiatric disorders among cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Mental disorders in cancer patients: a study of 100 psychiatric referrals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

The cognitive effects of the administration of narcotic analgesics in patients with cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Driving ability in cancer patients receiving long-term morphine analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Self-reports are not related to objective assessments of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

A phase II study of methylphenidate for depression in advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Modafinil affects mood, but not cognitive function, in healthy young volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

Modafinil attenuates disruptions in cognitive performance during simulated night-shift work

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216309106872

21 January 2018

Identifiers

DOI

10.1177/0269216309106872

1 reference

18 November 2017

1 reference

PubMed ID

19648224